期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

银杏达莫注射液联合替罗非班治疗冠脉支架术后出血2例 被引量：2

暂未订购
导出
摘要 冠心病是目前危害人类健康的常见疾病之一,介入手术由于创伤小、效果肯定,能改善急性冠脉综合征病人的预后和慢性稳定型心绞痛病人的症状,从而得到临床认可并广泛应用。药物支架能显著降低支架内再狭窄发生率,但由此带来了因内皮化延迟支架内血栓形成的风险,因此冠脉介入指南建议药物支架双联抗血小板治疗,但出血并发症随之出现。近年来报道的术后出血并发症多为穿刺部位的皮下血肿、冠状动脉破裂致心包压塞,
作者 路美娟 时晓迟 汪子涵 汪涛
机构地区 天津中医药大学 天津中医药大学第二附属医院 天津医科大学
出处 《中西医结合心脑血管病杂志》 2017年第7期894-895,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 冠心病 支架术后出血 银杏达莫注射液 替罗非班
分类号 R541.4 [医药卫生—心血管疾病] R289.5 [医药卫生—方剂学]
  • 相关文献

参考文献3

二级参考文献43

  • 1Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation ). Eur Heart J ,2006,27 : 1979-2030.
  • 2King SB Ⅲ,Smith SC Jr,Hirshfeld JW Jr,et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol ,2008,51 : 172-209.
  • 32009 Focused Updates:ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention( Updating the 2005 Guideline and 2007 Focused Update) :A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol,2009, (Online published).
  • 4Karjalainen PP, Porela P, Ylitalo A, et al. Safety and efficacy of cozn- hined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J, 2007,28:726-732.
  • 5Orford JL, Fasseas P, Melby S,el al. Safety and efficacy of aspirin, clopidogrel,and warfarin after coronary stent placement in patients with an indication for anticoagutation. Am Heart J,2004,147:463-467.
  • 6Manzano-Fernández S, Pastor FJ, Marin F, et al. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest,2008, 134 : 559-567.
  • 7Nguyen MC, Lira YL, Walton A,et al; GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry. of Acute Coronary Events : is it safe and effective to use just one antiplatelet agent? Eur Heart J,2007,28 : 1717-1722.
  • 8DeEugenio D,Kolman L, DeCaro M, et al. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy ,2007,27:691-696.
  • 9The ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan tbr prevention of Vascular Events ( ACTIVE-W ) : a randomized controlled trial. Lancet, 2006,367 : 1903-1912.
  • 10Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA ,2001,285:2864-2870.

共引文献33

同被引文献5

二级引证文献4

中西医结合心脑血管病杂志
2017年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部